Pfizer wins first US trial over Zoloft birth-defect risk

April 17, 2015 11:55 PM

12 0

Pfizer wins first US trial over Zoloft birth-defect risk

[NEW YORK] Pfizer Inc scored a key victory Friday when it was cleared of liability in the first US trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant.

Plaintiff Kristyn Pesante claimed that Pfizer failed to warn that using Zoloft during pregnancy could cause birth defects and sought damages after her son was born with a rare, serious congenital heart problem.

Also read: Supreme Court Strikes Down Two North Carolina Congressional Districts

Read more

To category page

Loading...